Products

SENSICARDIAC
DIACOUSTIC MEDICAL (PTY)
Cardiology AI
SENSICARDIAC by DIACOUSTIC MEDICAL (PTY) is an AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological, aiding physicians in diagnosis and reducing unnecessary referrals.

See all 1 product →

About DIACOUSTIC MEDICAL (PTY)

Stone Three Healthcare, operating in the healthcare AI sector, focuses on enabling and enhancing virtual consultations through computer-assisted diagnostic solutions. Their primary goal is to assist primary healthcare providers in better diagnosing and managing cardiovascular disease (CVD). The company leverages machine learning to extract valuable insights from health data related to cardiovascular health, which in turn helps in diagnosing and prioritizing patients who require urgent care.

Their core technological offerings revolve around medical visualization and precision telemedicine, built upon their extensive experience in medical device and data interoperability. Key products include TeleSensi™ and TeleSensi™ Cardiac, an artificial intelligence tool that utilizes digital stethoscopes for the remote screening of pathological heart murmurs. Stone Three Healthcare also provides virtual care solutions and services designed to expand the reach of healthcare and reduce costs, particularly in remote and underserved areas. While they also have industrial AI applications, their healthcare division is dedicated to improving patient outcomes through innovative digital health solutions.

What Physicians Need to Know

Specialization: Cardiac Acoustic AI
DIACOUSTIC MEDICAL (PTY) specializes in healthcare AI tools for cardiac diagnostics, particularly focusing on the analysis of heart sounds to distinguish between normal and pathological heart murmurs. Their flagship product, SensiCardiac Mobi, leverages acoustic AI for this purpose.
Key Differentiator: Proprietary Algorithm & High Accuracy
A core differentiator is their 'Sensi Diagnostic Heart Murmur Algorithm,' which runs on a hosted server environment with a Linux operating system. The mobile application, powered by this algorithm, demonstrates approximately 92% accuracy in detecting heart abnormalities, a rate comparable to or potentially exceeding human analysis in auscultation.
Key Differentiator: On-Device Data Processing & Privacy
The SensiCardiac Mobi application processes recordings locally on the mobile device, eliminating the need to upload sensitive patient data to a server or cloud for evaluation. This feature significantly enhances data privacy and offers greater flexibility to users.
Technology Stack: Acoustic Signal Processing & Machine Learning
Their technology stack includes the Sensi Diagnostic Heart Murmur Algorithm, a hosted server environment (Linux OS), and mobile handheld devices (e.g., iPhone 4S or later). It utilizes compatible electronic stethoscopes (e.g., ThinkLabs Medical ds32a+) to capture heart sounds as standard .wav files. The AI employs an ensemble nearest neighbors classifier and extracts features using Mel-frequency cepstral coefficients (MFCCs) and statistical properties of fundamental heart sounds.
Physician Tip

For physicians, DIACOUSTIC MEDICAL's SensiCardiac Mobi offers objective, AI-powered decision support for heart sound evaluation, aiding in the accurate and timely detection of heart murmurs. Its high diagnostic accuracy (around 92%) can augment clinical judgment, especially in distinguishing subtle acoustic differences. The mobile and portable nature of the solution allows for flexible use in various clinical settings, and the on-device data processing ensures patient data privacy. Physicians can benefit from real-time insights provided by the application's continuous output of predicted diagnoses, streamlining workflow and potentially improving patient outcomes by facilitating earlier intervention. It's important to remember that it serves as a support tool and not a sole diagnostic means.

While specific integration partners are not detailed, the system's architecture, involving a mobile application, electronic stethoscope, and a hosted server environment, suggests potential for integration with Electronic Health Records (EHR) systems for comprehensive patient data management, and potentially with telemedicine platforms for remote cardiac assessments. The use of standard .wav files for audio recording also indicates a degree of interoperability.

Products by DIACOUSTIC MEDICAL (PTY)

1 product in the directory

SENSICARDIAC
DIACOUSTIC MEDICAL (PTY)
Cardiology AI
SENSICARDIAC by DIACOUSTIC MEDICAL (PTY) is an AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological, aiding physicians in diagnosis and reducing unnecessary referrals.

What the Web Says

Reviews for DIACOUSTIC MEDICAL (PTY) are scarce across major review platforms like G2, Glassdoor, Capterra, and Reddit. The provided YouTube link is a product demonstration, not a review. Therefore, comprehensive product or employer reviews are not readily available from the requested sources.

Overall: Mixed

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers (general search)

Last updated: 2026-07-17

Videos

News, demos, and interviews about DIACOUSTIC MEDICAL (PTY).

Loading videos...

Videos load interactively. If none appear, search YouTube for DIACOUSTIC MEDICAL (PTY) →

View all on YouTube

Press & Coverage

MD+DI (Medical Device and Diagnostic Industry)
Innovative Medical Devices from Around the Worldu2014Diacoustic Medical
This article from 2015 highlights Diacoustic Medical Devices from South Africa as an innovative medical device company. It features an image related to SensiCardiac/Diacoustic Medical Devices.
2015-07
PubMed Central (PMC)
Body Acoustics for the Non-Invasive Diagnosis of Medical Conditions - PMC
This peer-reviewed article discusses the advances in non-invasive monitoring methods based on body acoustics for various medical conditions, including cardiovascular diseases. It highlights the potential of biomedical acoustic signals for remote patient monitoring.
2022-04
PR Newswire
Datasea Achieves Breakthrough in Acoustic Technology, Accelerating Billion-Dollar Commercialization in Healthcare - PR Newswire
Datasea Inc. announced a breakthrough in its acoustic technology, integrating sound wave coupling with AI for precision health management and clinical intervention. The company aims to address a healthcare application market projected to exceed $100 billion in China and approach $90 billion globally by 2030.
2025-08
Ear & Hearing
The Earphone Project pilot: a tele-otology study for remote Aboriginal communities - Saxby
This study, published in September 2024, explores tele-otology for remote Aboriginal communities, assessing the effectiveness of tele-assessment for ear conditions. It mentions the use of various devices including video otoscopes.
2024-09
PubMed Central (PMC)
New Approaches and Technologies to Improve Accuracy of Acute Otitis Media Diagnosis
This article from December 2021 discusses new approaches and technologies to improve the accuracy of Acute Otitis Media (AOM) diagnosis, including video-otoscopy and the potential of AI in telemedicine for pediatric and ENT specialists.
2021-12
Aidoc News
Aidoc Receives FDA Breakthrough Device Designation for AI That Drafts Radiology Reports
Aidoc announced in June 2026 that its First Read AI product, designed to automatically draft radiology reports, received FDA Breakthrough Device Designation. This aims to reduce the reporting burden on radiologists and improve patient care.
2026-06
Aidoc News
Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical AI for Earlier, Safer Diagnoses
In April 2026, Aidoc secured $150 million in Series E funding, led by Goldman Sachs, to expand its clinical AI solutions for earlier and safer diagnoses.
2026-04
OtoNexus Company News and Updates
OtoNexus Medical Technologies Awarded Top 10 Infection Control Solution Providers 2022 by MedTech Outlook
OtoNexus Medical Technologies was recognized as a Top 10 Infection Control Solution Provider in 2022 by MedTech Outlook for its role in providing data to physicians for responsible antimicrobial stewardship.
2022-XX

Frequently Asked Questions

DIACOUSTIC MEDICAL (PTY), through its 'AI Diagnostics' brand, offers an AI-powered digital stethoscope designed for the early and accurate detection of Tuberculosis (TB). They also provide the 'Sensicardiac Mobi' and 'Sensicardiac Mobi Diagnostic Heart Murmur Application,' which are clinical care, diagnostic support, and patient-facing tools. The TB screening solution utilizes an AI model built and validated on over 30,000 lung recordings to identify patterns uniquely associated with the disease.
DIACOUSTIC MEDICAL (PTY)'s AI-powered TB screening device is SAHPRA Approved, indicating adherence to relevant South African health product regulations. Generally, AI in healthcare is governed by a complex landscape of privacy laws, security standards, and emerging AI-specific frameworks such as HIPAA, GDPR, and the EU AI Act, which focus on patient safety, data security, and ethical deployment. While specific details for all Diacoustic products are not available, regulatory compliance is crucial for medical devices, with oversight bodies like the FDA and WHO providing guidance on ethical AI use.
The AI-powered digital stethoscope for TB screening is marketed as affordable and aligns with the World Health Organization's TB Screening Cost Guidelines. Its pricing includes hardware, training, software setup, and shipping, with no consumables or hidden costs. In general, healthcare decision-makers prefer transparent and predictable pricing models, often hybrid structures combining a base fee with variable components based on clinically meaningful units like per patient or per test, rather than opaque usage-based metrics.
For their AI-powered TB screening solution, DIACOUSTIC MEDICAL (PTY) includes training as part of the offering, ensuring users can effectively operate the digital stethoscope and interpret results. While specific details for all products are not available, comprehensive support for healthcare AI solutions typically encompasses technical assistance, troubleshooting guides, and product documentation to ensure seamless integration and ongoing functionality within clinical workflows.
Information regarding specific partnerships between DIACOUSTIC MEDICAL (PTY) and other healthcare technology providers or institutions was not readily available in the provided search results. However, collaborations are common in the evolving healthcare AI landscape to enhance product development, integration, and market reach.
While direct information on the overall company stability and long-term vision for DIACOUSTIC MEDICAL (PTY) was not explicitly detailed in the search results, their offering of SAHPRA-approved AI diagnostic tools for critical health issues like TB suggests an active presence in the medical device market. The broader healthcare AI market is experiencing significant growth, with a focus on improving efficiency, accuracy, and patient outcomes, indicating a dynamic environment for companies in this sector.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]

Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.